Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?
- PMID: 20493770
- DOI: 10.1016/S1470-2045(10)70120-0
Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?
Comment on
-
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.Lancet Oncol. 2010 Jun;11(6):521-9. doi: 10.1016/S1470-2045(10)70112-1. Epub 2010 May 20. Lancet Oncol. 2010. PMID: 20493771 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
